effects [qlco]
ROUTE [ftcn]
Estrogen [horm, phsu, strd]
Administration [ocac]
IGF-1 [aapp, bacs]
IGFBP-3 [aapp, bacs, phsu]
Health [idcn]
postmenopausal [tmco]
Women [popg]
randomized [resa]
placebo controlled study [inpr, resa]
Objective [inpr]
Oestrogens [horm, phsu, strd]
modulate [spco]
Action [ftcn]
secretion [biof]
GH [aapp, enzy]
Previous [tmco]
postmenopausal [tmco]
Women [popg]
Differential [qlco]
Transdermal [ftcn]
17 beta-Estradiol [horm, phsu, strd]
Oral [spco]
Ethinyl Estradiol [horm, phsu, strd]
GH [aapp, enzy]
IGF-1 [aapp, bacs]
Concentrations [menp]
secondary [neop]
Based [ftcn]
Large [qnco]
randomized [resa]
Trial [resa]
Estimate [qnco]
ROUTE [ftcn]
Administration [ocac]
17 beta-Estradiol [horm, phsu, strd]
Combined [qlco]
Hormone replacement therapy [topp]
Progesterone [horm, phsu, strd]
IGF-1 [aapp, bacs]
IGFBP-3 [aapp, bacs, phsu]
Levels [qlco]
Design [acty]
IGF-1 [aapp, bacs]
IGFBP-3 [aapp, bacs, phsu]
Evaluated [ftcn]
randomized [resa]
Study [mnob]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Continuous [idcn]
Basis [ftcn]
mg% [qnco]
17 beta-Estradiol [horm, phsu, strd]
Orally [spco]
Combined [qlco]
Daily [tmco]
Intake [ftcn]
mg% [qnco]
Progesterone [horm, phsu, strd]
Group 1 [inpr]
N NOS [aapp, imft]
mU/g [qnco]
17 beta-Estradiol [horm, phsu, strd]
Combined [qlco]
Daily [tmco]
Intake [ftcn]
mg% [qnco]
Progesterone [horm, phsu, strd]
Group 2 [inpr]
N NOS [aapp, imft]
Triple [qnco]
placebo [topp]
Group 3 [inpr]
N NOS [aapp, imft]
IGF-1 [aapp, bacs]
IGFBP-3 [aapp, bacs, phsu]
Levels [qlco]
Available [ftcn]
Women [popg]
Oral [spco]
Estrogen [horm, phsu, strd]
Decreased [qnco]
IGF-1 [aapp, bacs]
Compared [acty]
placebo [topp]
P NOS [aapp, imft]
transdermal estrogen [horm, phsu, strd]
P NOS [aapp, imft]
transdermal estrogen [horm, phsu, strd]
IGF-1 [aapp, bacs]
Compared [acty]
placebo [topp]
P NOS [aapp, imft]
IGFBP-3 [aapp, bacs, phsu]
Detected [fndg]
Group [idcn]
ROUTE [ftcn]
Estrogen [horm, phsu, strd]
Administration [ocac]
IGF-1 [aapp, bacs]
IGF-1 [aapp, bacs]
Concentrations [menp]
Decreased [qnco]
Oral [spco]
Estrogen [horm, phsu, strd]
Observed [ftcn]
transdermal estrogen [horm, phsu, strd]
months [tmco]
Relevance [qlco]
Differential [qlco]
effects [qlco]
Cardiovascular Diseases [dsyn]
